UWE TITT

TitleAssociate Professor
InstitutionMD Anderson
DepartmentRadiation Physics
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Titt U, Yang M, Wang X, Iga K, Fredette N, Schueler E, Lin SH, Zhu XR, Sahoo N, Koong AC, Zhang X, Mohan R. Design and validation of a synchrotron proton beam line for FLASH radiotherapy preclinical research experiments. Med Phys. 2021 Nov 20. PMID: 34800037.
      Citations:    Fields:    
    2. Bronk L, Guan F, Patel D, Ma D, Kroger B, Wang X, Tran K, Yiu J, Stephan C, Debus J, Abdollahi A, Jäkel O, Mohan R, Titt U, Grosshans DR. Mapping the Relative Biological Effectiveness of Proton, Helium and Carbon Ions with High-Throughput Techniques. Cancers (Basel). 2020 Dec 05; 12(12). PMID: 33291477.
      Citations: 3     
    3. Titt U, Pera E, Gillin MT. Monte Carlo Simulations of Neutron Ambient Dose Equivalent in a Novel Proton Therapy Facility Design. Int J Part Ther. 2020; 6(4):29-37. PMID: 32582817.
      Citations:    
    4. Bright SJ, Flint DB, Chakraborty S, McFadden CH, Yoon DS, Bronk L, Titt U, Mohan R, Grosshans DR, Sumazin P, Shaitelman SF, Asaithamby A, Sawakuchi GO. Nonhomologous End Joining Is More Important Than Proton Linear Energy Transfer in Dictating Cell Death. Int J Radiat Oncol Biol Phys. 2019 12 01; 105(5):1119-1125. PMID: 31425731.
      Citations: 4     Fields:    Translation:HumansCells
    5. Newpower M, Schuemann J, Mohan R, Paganetti H, Titt U. Comparing 2 Monte Carlo Systems in Use for Proton Therapy Research. Int J Part Ther. 2019; 6(1):18-27. PMID: 31773045.
      Citations:    
    6. Yepes P, Adair A, Frank SJ, Grosshans DR, Liao Z, Liu A, Mirkovic D, Poenisch F, Titt U, Wang Q, Mohan R. Fixed- versus Variable-RBE Computations for Intensity Modulated Proton Therapy. Adv Radiat Oncol. 2019 Jan-Mar; 4(1):156-167. PMID: 30706024.
      Citations: 3     
    7. Guan F, Geng C, Ma D, Bronk L, Kerr M, Li Y, Gates D, Kroger B, Sahoo N, Titt U, Grosshans D, Mohan R. RBE Model-Based Biological Dose Optimization for Proton Radiobiology Studies. Int J Part Ther. 2018; 5(1):160-171. PMID: 30338268.
      Citations: 7     
    8. Taleei R, Guan F, Peeler C, Bronk L, Patel D, Mirkovic D, Grosshans DR, Mohan R, Titt U. Erratum: "Monte Carlo simulations of 3 He ion physical characteristics in a water phantom and evaluation of radiobiological effectiveness" [Med. Phys. 43 (2), page range 761-776(2016)]. Med Phys. 2018 Mar; 45(3):1301. PMID: 29527699.
      Citations:    Fields:    
    9. Yepes P, Adair A, Grosshans D, Mirkovic D, Poenisch F, Titt U, Wang Q, Mohan R. Comparison of Monte Carlo and analytical dose computations for intensity modulated proton therapy. Phys Med Biol. 2018 02 09; 63(4):045003. PMID: 29339570.
      Citations: 10     Fields:    Translation:Humans
    10. Wu RY, Liu AY, Sio TT, Blanchard P, Wages C, Amin MV, Gunn GB, Titt U, Ye R, Suzuki K, Gillin MT, Zhu XR, Mohan R, Frank SJ. Intensity-Modulated Proton Therapy Adaptive Planning for Patients with Oropharyngeal Cancer. Int J Part Ther. 2017; 4(2):26-34. PMID: 31773006.
      Citations: 7     
    11. Titt U, Suzuki K, Li Y, Sahoo N, Gillin MT, Zhu XR. Technical Note: Dosimetric characteristics of the ocular beam line and commissioning data for an ocular proton therapy planning system at the Proton Therapy Center Houston. Med Phys. 2017 Dec; 44(12):6661-6671. PMID: 28975637.
      Citations:    Fields:    
    12. Niedzielski JS, Yang J, Mohan R, Titt U, Mirkovic D, Stingo F, Liao Z, Gomez DR, Martel MK, Briere TM, Court LE. Differences in Normal Tissue Response in the Esophagus Between Proton and Photon Radiation Therapy for Non-Small Cell Lung Cancer Using In Vivo Imaging Biomarkers. Int J Radiat Oncol Biol Phys. 2017 11 15; 99(4):1013-1020. PMID: 29063837.
      Citations:    Fields:    Translation:Humans
    13. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28880368.
      Citations: 6     Fields:    Translation:HumansCells
    14. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 29527697.
      Citations:    Fields:    
    15. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28517438.
      Citations:    Fields:    
    16. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 34822721.
      Citations:    Fields:    
    17. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 18367789.
      Citations: 21     Fields:    Translation:HumansCells
    18. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17022221.
      Citations: 10     Fields:    Translation:HumansCells
    19. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16381702.
      Citations: 10     Fields:    
    20. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16696457.
      Citations: 33     Fields:    Translation:Cells
    21. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17153419.
      Citations: 28     Fields:    
    22. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19147246.
      Citations: 9     Fields:    Translation:Humans
    23. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22320798.
      Citations: 1     Fields:    
    24. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22617113.
      Citations:    Fields:    
    25. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22996039.
      Citations: 10     Fields:    Translation:Humans
    26. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17544596.
      Citations: 12     Fields:    Translation:HumansCells
    27. Peeler CR, Mirkovic D, Titt U, Blanchard P, Gunther JR, Mahajan A, Mohan R, Grosshans DR. Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma. Radiother Oncol. 2016 12; 121(3):395-401. PMID: 27863964.
      Citations: 47     Fields:    Translation:HumansCells
    28. Mikell J, Cheenu Kappadath S, Wareing T, Erwin WD, Titt U, Mourtada F. Evaluation of a deterministic grid-based Boltzmann solver (GBBS) for voxel-level absorbed dose calculations in nuclear medicine. Phys Med Biol. 2016 06 21; 61(12):4564-82. PMID: 27224727.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    29. Yepes PP, Eley JG, Liu A, Mirkovic D, Randeniya S, Titt U, Mohan R. Validation of a track repeating algorithm for intensity modulated proton therapy: clinical cases study. Phys Med Biol. 2016 Apr 07; 61(7):2633-45. PMID: 26961764.
      Citations: 6     Fields:    Translation:Humans
    30. Taleei R, Guan F, Peeler C, Bronk L, Patel D, Mirkovic D, Grosshans DR, Mohan R, Titt U. Monte Carlo simulations of ³He ion physical characteristics in a water phantom and evaluation of radiobiological effectiveness. Med Phys. 2016 Feb; 43(2):761-76. PMID: 26843239.
      Citations: 3     Fields:    
    31. Guan F, Peeler C, Bronk L, Geng C, Taleei R, Randeniya S, Ge S, Mirkovic D, Grosshans D, Mohan R, Titt U. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code. Med Phys. 2015 Nov; 42(11):6234-47. PMID: 26520716.
      Citations: 24     Fields:    Translation:HumansCells
    32. Titt U, Sell M, Unkelbach J, Bangert M, Mirkovic D, Oelfke U, Mohan R. Degradation of proton depth dose distributions attributable to microstructures in lung-equivalent material. Med Phys. 2015 Nov; 42(11):6425-32. PMID: 26520732.
      Citations: 5     Fields:    Translation:HumansCells
    33. Guan F, Bronk L, Titt U, Lin SH, Mirkovic D, Kerr MD, Zhu XR, Dinh J, Sobieski M, Stephan C, Peeler CR, Taleei R, Mohan R, Grosshans DR. Spatial mapping of the biologic effectiveness of scanned particle beams: towards biologically optimized particle therapy. Sci Rep. 2015 May 18; 5:9850. PMID: 25984967.
      Citations: 35     Fields:    Translation:HumansCells
    34. Perles LA, Mirkovic D, Anand A, Titt U, Mohan R. LET dependence of the response of EBT2 films in proton dosimetry modeled as a bimolecular chemical reaction. Phys Med Biol. 2013 Dec 07; 58(23):8477-91. PMID: 24240474.
      Citations: 6     Fields:    Translation:Cells
    35. Newhauser WD, Rechner L, Mirkovic D, Yepes P, Koch NC, Titt U, Fontenot JD, Zhang R. Benchmark measurements and simulations of dose perturbations due to metallic spheres in proton beams. Radiat Meas. 2013 Nov 01; 58:37-44. PMID: 25147474.
      Citations: 3     Fields:    
    36. Cho J, Ibbott G, Gillin M, Gonzalez-Lepera C, Titt U, Paganetti H, Kerr M, Mawlawi O. Feasibility of proton-activated implantable markers for proton range verification using PET. Phys Med Biol. 2013 Nov 07; 58(21):7497-512. PMID: 24099853.
      Citations: 4     Fields:    
    37. Zhu XR, Poenisch F, Lii M, Sawakuchi GO, Titt U, Bues M, Song X, Zhang X, Li Y, Ciangaru G, Li H, Taylor MB, Suzuki K, Mohan R, Gillin MT, Sahoo N. Commissioning dose computation models for spot scanning proton beams in water for a commercially available treatment planning system. Med Phys. 2013 Apr; 40(4):041723. PMID: 23556893.
      Citations: 26     Fields:    
    38. Yang M, Zhu XR, Park PC, Titt U, Mohan R, Virshup G, Clayton JE, Dong L. Comprehensive analysis of proton range uncertainties related to patient stopping-power-ratio estimation using the stoichiometric calibration. Phys Med Biol. 2012 Jul 07; 57(13):4095-115. PMID: 22678123.
      Citations: 53     Fields:    Translation:Humans
    39. Mirkovic D, Titt U, Mohan R. SU-E-T-484: Potential Clinical Impact of Dosimetric Uncertainties in Proton Therapy. Med Phys. 2012 Jun; 39(6Part17):3816. PMID: 28517453.
      Citations:    Fields:    
    40. Bangert M, Titt U, Ziegenhein P, Mohan R, Oelfke U. SU-E-T-396: Beam Angle Optimization for IMPT Comparing Gantries and Fixed Beam Lines. Med Phys. 2012 Jun; 39(6Part16):3795. PMID: 28517218.
      Citations:    Fields:    
    41. Sell M, Titt U, Perles L, Mirkovic D, Mohan R, Bangert M, Oelfke U. WE-E-BRB-02: Evaluation of Analytical Proton Dose Predictions with a Lung-Like Plastic Phantom. Med Phys. 2012 Jun; 39(6Part27):3956. PMID: 28520021.
      Citations:    Fields:    
    42. Titt U, Mirkovic D, Liu A, Mohan R. SU-E-T-435: Automatic Monte Carlo Dose Calculations of Proton Treatment Plans. Med Phys. 2012 Jun; 39(6Part16):3805. PMID: 28517181.
      Citations:    Fields:    
    43. Yepes PP, Brannan T, Huang J, Mirkovic D, Newhauser WD, Taddei PJ, Titt U. Application of a fast proton dose calculation algorithm to a thorax geometry. Radiat Meas. 2010 Dec 01; 45(10):1367-1368. PMID: 21544230.
      Citations: 2     Fields:    
    44. Fontenot JD, Bloch C, Followill D, Titt U, Newhauser WD. Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy. Phys Med Biol. 2010 Dec 07; 55(23):6987-98. PMID: 21076196.
      Citations: 12     Fields:    Translation:Humans
    45. Titt U, Mirkovic D, Sawakuchi GO, Perles LA, Newhauser WD, Taddei PJ, Mohan R. Adjustment of the lateral and longitudinal size of scanned proton beam spots using a pre-absorber to optimize penumbrae and delivery efficiency. Phys Med Biol. 2010 Dec 07; 55(23):7097-106. PMID: 21076194.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    46. Sawakuchi GO, Mirkovic D, Perles LA, Sahoo N, Zhu XR, Ciangaru G, Suzuki K, Gillin MT, Mohan R, Titt U. An MCNPX Monte Carlo model of a discrete spot scanning proton beam therapy nozzle. Med Phys. 2010 Sep; 37(9):4960-70. PMID: 20964215.
      Citations: 20     Fields:    
    47. Sawakuchi GO, Sahoo N, Gasparian PB, Rodriguez MG, Archambault L, Titt U, Yukihara EG. Determination of average LET of therapeutic proton beams using Al2O3:C optically stimulated luminescence (OSL) detectors. Phys Med Biol. 2010 Sep 07; 55(17):4963-76. PMID: 20693613.
      Citations: 2     Fields:    Translation:Cells
    48. Sawakuchi GO, Zhu XR, Poenisch F, Suzuki K, Ciangaru G, Titt U, Anand A, Mohan R, Gillin MT, Sahoo N. Experimental characterization of the low-dose envelope of spot scanning proton beams. Phys Med Biol. 2010 Jun 21; 55(12):3467-78. PMID: 20508318.
      Citations: 15     Fields:    
    49. Sawakuchi GO, Titt U, Mirkovic D, Ciangaru G, Zhu XR, Sahoo N, Gillin MT, Mohan R. Monte Carlo investigation of the low-dose envelope from scanned proton pencil beams. Phys Med Biol. 2010 Feb 07; 55(3):711-21. PMID: 20071752.
      Citations: 17     Fields:    
    50. Gillin MT, Sahoo N, Bues M, Ciangaru G, Sawakuchi G, Poenisch F, Arjomandy B, Martin C, Titt U, Suzuki K, Smith AR, Zhu XR. Commissioning of the discrete spot scanning proton beam delivery system at the University of Texas M.D. Anderson Cancer Center, Proton Therapy Center, Houston. Med Phys. 2010 Jan; 37(1):154-63. PMID: 20175477.
      Citations: 65     Fields:    
    51. Taddei PJ, Mirkovic D, Fontenot JD, Giebeler A, Zheng Y, Titt U, Woo S, Newhauser WD. REDUCING STRAY RADIATION DOSE FOR A PEDIATRIC PATIENT RECEIVING PROTON CRANIOSPINAL IRRADIATION. Nucl Technol. 2009 Oct 01; 168(1):108-112. PMID: 20865143.
      Citations: 9     
    52. Vassiliev ON, Kry SF, Chang JY, Balter PA, Titt U, Mohan R. Stereotactic radiotherapy for lung cancer using a flattening filter free Clinac. J Appl Clin Med Phys. 2009 Jan 27; 10(1):14-21. PMID: 19223837.
      Citations: 31     Fields:    Translation:Humans
    53. Vassiliev ON, Wareing TA, Davis IM, McGhee J, Barnett D, Horton JL, Gifford K, Failla G, Titt U, Mourtada F. Feasibility of a multigroup deterministic solution method for three-dimensional radiotherapy dose calculations. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):220-7. PMID: 18722273.
      Citations: 16     Fields:    Translation:Humans
    54. Sawakuchi GO, Titt U, Mirkovic D, Mohan R. Density heterogeneities and the influence of multiple Coulomb and nuclear scatterings on the Bragg peak distal edge of proton therapy beams. Phys Med Biol. 2008 Sep 07; 53(17):4605-19. PMID: 18678928.
      Citations: 17     Fields:    Translation:Humans
    55. Titt U, Sahoo N, Ding X, Zheng Y, Newhauser WD, Zhu XR, Polf JC, Gillin MT, Mohan R. Assessment of the accuracy of an MCNPX-based Monte Carlo simulation model for predicting three-dimensional absorbed dose distributions. Phys Med Biol. 2008 Aug 21; 53(16):4455-70. PMID: 18670050.
      Citations: 22     Fields:    Translation:Humans
    56. Kry SF, Howell RM, Titt U, Salehpour M, Mohan R, Vassiliev ON. Energy spectra, sources, and shielding considerations for neutrons generated by a flattening filter-free Clinac. Med Phys. 2008 May; 35(5):1906-11. PMID: 18561666.
      Citations: 12     Fields:    Translation:Humans
    57. Taddei PJ, Fontenot JD, Zheng Y, Mirkovic D, Lee AK, Titt U, Newhauser WD. Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer. Phys Med Biol. 2008 Apr 21; 53(8):2131-47. PMID: 18369278.
      Citations: 23     Fields:    Translation:Humans
    58. Titt U, Zheng Y, Vassiliev ON, Newhauser WD. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method. Phys Med Biol. 2008 Jan 21; 53(2):487-504. PMID: 18185001.
      Citations: 27     Fields:    Translation:HumansPHPublic Health
    59. Polf JC, Harvey MC, Titt U, Newhauser WD, Smith AR. Initial beam size study for passive scatter proton therapy. I. Monte Carlo verification. Med Phys. 2007 Nov; 34(11):4213-8. PMID: 18072485.
      Citations: 7     Fields:    Translation:Humans
    60. Kry SF, Titt U, Followill D, Pönisch F, Vassiliev ON, White RA, Stovall M, Salehpour M. A Monte Carlo model for out-of-field dose calculation from high-energy photon therapy. Med Phys. 2007 Sep; 34(9):3489-99. PMID: 17926952.
      Citations: 17     Fields:    Translation:Humans
    61. Vassiliev ON, Titt U, Kry SF, Mohan R, Gillin MT. Radiation safety survey on a flattening filter-free medical accelerator. Radiat Prot Dosimetry. 2007; 124(2):187-90. PMID: 17681966.
      Citations: 5     Fields:    Translation:CellsPHPublic Health
    62. Kry SF, Titt U, Pönisch F, Vassiliev ON, Salehpour M, Gillin M, Mohan R. Reduced neutron production through use of a flattening-filter-free accelerator. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1260-4. PMID: 17637397.
      Citations: 21     Fields:    Translation:HumansCellsPHPublic Health
    63. Newhauser W, Fontenot J, Zheng Y, Polf J, Titt U, Koch N, Zhang X, Mohan R. Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm. Phys Med Biol. 2007 Aug 07; 52(15):4569-84. PMID: 17634651.
      Citations: 49     Fields:    
    64. Fontenot JD, Newhauser WD, Bloch C, White RA, Titt U, Starkschall G. Determination of output factors for small proton therapy fields. Med Phys. 2007 Feb; 34(2):489-98. PMID: 17388166.
      Citations: 11     Fields:    Translation:Humans
    65. Titt U, Vassiliev ON, Pönisch F, Dong L, Liu H, Mohan R. A flattening filter free photon treatment concept evaluation with Monte Carlo. Med Phys. 2006 Jun; 33(6):1595-602. PMID: 16872067.
      Citations: 28     Fields:    
    66. Pönisch F, Titt U, Vassiliev ON, Kry SF, Mohan R. Properties of unflattened photon beams shaped by a multileaf collimator. Med Phys. 2006 Jun; 33(6):1738-46. PMID: 16872081.
      Citations: 47     Fields:    Translation:HumansCells
    67. Vassiliev ON, Titt U, Pönisch F, Kry SF, Mohan R, Gillin MT. Dosimetric properties of photon beams from a flattening filter free clinical accelerator. Phys Med Biol. 2006 Apr 07; 51(7):1907-17. PMID: 16552113.
      Citations: 58     Fields:    
    68. Pönisch F, Titt U, Kry SF, Vassiliev ON, Mohan R. MCNPX simulation of a multileaf collimator. Med Phys. 2006 Feb; 33(2):402-4. PMID: 16532947.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    69. Newhauser W, Koch N, Hummel S, Ziegler M, Titt U. Monte Carlo simulations of a nozzle for the treatment of ocular tumours with high-energy proton beams. Phys Med Biol. 2005 Nov 21; 50(22):5229-49. PMID: 16264250.
      Citations: 17     Fields:    Translation:Humans
    70. Newhauser WD, Ding X, Giragosian D, Nill S, Titt U. Neutron radiation area monitoring system for proton therapy facilities. Radiat Prot Dosimetry. 2005; 115(1-4):149-53. PMID: 16381703.
      Citations: 2     Fields:    Translation:PHPublic Health
    71. Bues M, Newhauser WD, Titt U, Smith AR. Therapeutic step and shoot proton beam spot-scanning with a multi-leaf collimator: a Monte Carlo study. Radiat Prot Dosimetry. 2005; 115(1-4):164-9. PMID: 16381706.
      Citations: 20     Fields:    Translation:HumansPHPublic Health
    72. Fontenot JD, Newhauser WD, Titt U. Design tools for proton therapy nozzles based on the double-scattering foil technique. Radiat Prot Dosimetry. 2005; 116(1-4 Pt 2):211-5. PMID: 16604629.
      Citations: 21     Fields:    Translation:HumansPHPublic Health
    73. Polf JC, Newhauser WD, Titt U. Patient neutron dose equivalent exposures outside of the proton therapy treatment field. Radiat Prot Dosimetry. 2005; 115(1-4):154-8. PMID: 16381704.
      Citations: 15     Fields:    Translation:HumansPHPublic Health
    74. Dangendorf V, Schuhmacher H, Titt U, Tittelmeier K. Imaging of microscopic features of charged particle tracks in a low-pressure gas. Radiat Prot Dosimetry. 2002; 99(1-4):353-4. PMID: 12194322.
      Citations:    Fields:    
    75. Reducing stray radiation dose for a pediatric patient receiving proton craniospinal irradiation. 587-588.
    76. Concept of a neutron dosemeter based on a recoil particle track chamber. Radiation Protection Dosimetry. 70:219-224.
    77. Benchmark measurements and simulations of dose perturbations due to metallic spheres in proton beams. Radiation Measurements. 58:37-44.
    78. Monte carlo proton radiation therapy planning calculations. 63-64.
    79. Monte Carlo simulations of 3He ion physical characteristics in a water phantom and evaluation of radiobiological effectiveness. Medical Physics. 43:761-776.
    80. Medical applications of optically stimulated luminescence dosimeters (OSLDs). Radiation Measurements. 45:658-662.
    81. Degradation of proton depth dose distributions attributable to microstructures in lung-equivalent material. Medical Physics. 42:6425-6432.
    82. A time projection chamber with optical readout for charged particle track structure imaging. Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 416:85-99.
    83. Treating patients with the NPTC accelerator based proton treatment facility. 690-693.
    84. Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma. Radiotherapy and Oncology. 121:395-401.
    85. Application of a fast proton dose calculation algorithm to a thorax geometry. Radiation Measurements. 45:1367-1368.
    86. Erratum. Physics in Medicine and Biology. 59:3239-3240.
    87. Spatial mapping of the biologic effectiveness of scanned particle beams. Scientific Reports. 5.
    88. Development and application of an optical TPC for charged particle track structure imaging in microdosimetry. Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 477:536-539.
    89. Monte carlo investigation of rebinning material density distributions of lung parenchyma phantoms in proton therapy. Nuclear Technology. 175:22-26.
    90. Monte Carlo model of a passively scattered proton therapy system. 252-255.
    91. Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field. Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 476:429-434.
    92. Evaluation of a deterministic grid-based Boltzmann solver (GBBS) for voxel-level absorbed dose calculations in nuclear medicine. Physics in Medicine and Biology. 61:4564-4582.
    93. Overview of radiation research to improve cancer survival. 19-20.
    94. Reducing stray radiation dose for a pediatric patient receiving proton craniospinal irradiation. Nuclear Technology. 168:108-112.
    95. Digital imaging of charged particle track structures with a low-pressure optical time projection chamber. Nuclear Physics B - Proceedings Supplements. 78:444-448.
    96. Neutron shielding verification measurements and simulations for a 235-MeV proton therapy center. Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 476:80-84.
    97. Validation of a track repeating algorithm for intensity modulated proton therapy. Physics in Medicine and Biology. 61:2633-2645.
    98. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant 4 Monte Carlo code. Medical Physics. 42:6234-6247.
    TITT's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (142)
    Explore
    _
    Co-Authors (35)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _